glp-1 mimetics Non-insulin injectable antidiabetic drugs - agonists and amylinomimetics Medicinal Chemistry of Incretin Mimetics

Its called training hard

[1] Alternative Options When GLP-1 Treatment Fails When GLP-1 medications prove ineffective despite optimisation, several alternative therapeutic strategies exist, depending on whether the primary goal is diabetes management or weight loss

Then there is the other side

Place under the tongue and hold for two minutes before swallowing

Regulatory bodies approved GLP-1 receptor agonists are TRULICITY (dulaglutide), BYETTA/BYDUREON (exenatide), VICTOZA (liraglutide), OZEMPIC/WEGOVY/RYBELSUS, (Semaglutide), MOUNJARO/ZEPBOUND (tirzepatide) and others

Eli Lillys performance illustrates how capturing a lead in a breakthrough therapy area can redefine a companys fortunes